Traws Pharma, Inc. — Director's Dealing 2013

Jul 29, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-07-25

Reporting Person: Hoffman Michael B (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-07-25	Stock Option (right to purchase)	$15	A	13000	Acquired	2023-07-25	Common Stock (13000)	Direct

Footnotes

F1: This option, representing a right to purchase a total of 13,000 shares of Common Stock, is immediately exercisable and vests over 12 months from July 25, 2013, with 1/12th vesting on August 25, 2013 and 11/12th vesting in 11 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.